Search Results - Liubao Peng

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Cover Image

    Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in Chi... by Xia Luo, Zhen Zhou, Xiaohui Zeng, Liubao Peng, Qiao Liu

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials by Ciyan Peng, Jing Chen, Wei Cui, Sini Li, Jianhe Li, Liubao Peng

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Clinical efficacy and safety of 16 Chinese patent medicines in combination with benzodiazepines/non-benzodiazepines for the treatment of chronic insomnia in adults: A multiple-trea... by Ciyan Peng, Jing Chen, Sini Li, Boyin Huang, Wei Cui, Jianhe Li, Liubao Peng

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Comparative efficacy and safety of various Chinese patent medicines combined with western medicine for adults with insomnia: A Bayesian network meta-analysis of randomized controll... by Ciyan Peng, Jing Chen, Sini Li, Boyin Huang, Wei Cui, Jianhe Li, Liubao Peng

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis by Qiao Liu, Zhen Zhou, Xia Luo, Lidan Yi, Liubao Peng, Xiaomin Wan, Chongqing Tan, Xiaohui Zeng

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 6
    Cover Image

    Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50% by Qiao Liu, Zhen Zhou, Xia Luo, Lidan Yi, Liubao Peng, Xiaomin Wan, Chongqing Tan, Xiaohui Zeng

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 7
    Cover Image

    Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell L... by Xia Luo, Qiao Liu, Zhen Zhou, Lidan Yi, Liubao Peng, Xiaomin Wan, Xiaohui Zeng, Chongqing Tan, Sini Li

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 8
    Cover Image

    Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer by Xiaomin Wan, Xiaohui Zeng, Liubao Peng, Ye Peng, Qiao Liu, Lidan Yi, Xia Luo, Qijian Deng, Qijian Deng, Chongqing Tan

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  9. 9
    Cover Image

    Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis by Ye Peng, Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: